Prodrug conversion in minipig hepatocytes assessed as (2S,3S,4S,5R,6R)-6-(2-(4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yloxy)et...

Basic Information

ID: ALA4367495

Type: ADME

Description: Prodrug conversion in minipig hepatocytes assessed as (2S,3S,4S,5R,6R)-6-(2-(4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yloxy)ethoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid formation at 20 uM measured after 4 hrs

Format: BAO_0000219

Organism: Sus scrofa

Cell type: Hepatocyte

Target:  ADMET(ALA612558)

Document:  ALA4364295

Prodrug conversion in minipig hepatocytes assessed as (2S,3S,4S,5R,6R)-6-(2-(4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yloxy)ethoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid formation at 20 uM measured after 4 hrs: 1

Activity Charts

Compound Summary

Parent Molecular WeightALogPPolar Surface Area
580.644.044.04